RUBY insider transactions
Rubius Therapeutics Inc. (RUBY) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for RUBY
- SEC Form 4: Appelhans Dannielle sold $1,323 worth of shares (10,385 units at $0.13), closing all direct ownership in the company4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4: Cagnoni Pablo J sold $2,112 worth of shares (8,448 units at $0.25), decreasing direct ownership by 11% to 66,082 units to cover withholding tax4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4: Appelhans Dannielle converted options into 7,500 shares and sold $970 worth of shares (3,878 units at $0.25), increasing direct ownership by 54% to 10,385 units to satisfy withholding tax4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4: Cagnoni Pablo J converted options into 46,250 shares and sold $1,745 worth of shares (7,240 units at $0.24), increasing direct ownership by 110% to 74,530 units (tax withholding)4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4: Turka Laurence A. converted options into 16,063 shares and sold $622 worth of shares (2,593 units at $0.24), increasing direct ownership by 274% to 18,391 units to satisfy withholding obligation4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4: Appelhans Dannielle converted options into 12,500 shares and sold $4,590 worth of shares (5,737 units at $0.80) to cover taxes4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by Schaffert Susanne4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 3 filed by new insider Schaffert Susanne3 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by Holles Natalie C.4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by Prener Anne4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by Symonds Jonathan4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by Afeyan Noubar4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by Cuss Francis M4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by Rosenblatt Michael4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by Sohn Catherine A.4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by Epstein David R4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4: Epstein David R bought $43,329 worth of shares (30,000 units at $1.44), increasing direct ownership by 0.64% to 4,720,012 units4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 5: Cagnoni Pablo J gifted 6,200 shares, decreasing direct ownership by 17% to 29,320 units5 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4: Cagnoni Pablo J converted options into 21,250 shares and sold $44,236 worth of shares (6,730 units at $6.57), increasing direct ownership by 69% to 35,520 units (for withholding tax)4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by Carmona Jose4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by Appelhans Dannielle4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4: Keson-Brookes Maiken converted options into 8,075 shares and sold $17,957 worth of shares (2,732 units at $6.57) to cover withholding tax4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4: Turka Laurence A. converted options into 7,438 shares and sold $16,544 worth of shares (2,517 units at $6.57) (withholding obligation)4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by Appelhans Dannielle4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 3 filed by Rubius Therapeutics, Inc.3 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by Epstein David R4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by Rosenblatt Michael4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by Sohn Catherine A.4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by AFEYAN NOUBAR4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by Symonds Jonathan4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by Cuss Francis M4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by Holles Natalie C.4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by Prener Anne4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4: Llc Partner General Iv Fund Ventures Flagship bought $6,090,000 worth of Common Stock (210,000 units at $29.00)4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4: Maiken Keson-Brookes exercised 25,000 units of Common Stock at a strike of $7.70 and sold $505,965 worth of Common Stock (25,000 units at $20.24)4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4: R David Epstein sold $398,560 worth of Common Stock (26,704 units at $14.93), decreasing ownership by 0.57% to 4,690,012 units4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4: R David Epstein sold $1,468,788 worth of Common Stock (98,737 units at $14.88), decreasing ownership by 2% to 4,716,716 units4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by Maiken Keson-Brookes4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by M. Christina Coughlin4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by A. Laurence Turka4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- SEC Form 4 filed by J Pablo Cagnoni4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)